Rozister^®

Treatment of hypercholesterolemia in adults, adolescents and children aged 10 years and older with primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia) or mixed dyslipidemia (type Ib) as an adjunct to diet, when dietary compliance and other nonpharmacological means (e.g. exercise, weight loss) are insufficient.

In homozygous familial hypercholesterolemia, as an adjunct to diet and other lipid-lowering treatments (e.g. LDL apheresis) or in cases where such treatment is inappropriate. Prevention of cardiovascular disorders Prevention of major cardiovascular disorders in patients who are assessed to be at high risk of a first cardiovascular event, as an adjunct to the correction of other risk factors.